SLC2A1 and cancer: In particular, the prognostic value of GLUT-1 expression is indicated in adenocarcinomas of the stomach [460,461], pancreas [462], and prostate [463,464]; carcinomas of the lungs [465] and endometrium [466,467]; and osteosarcoma [468], meningioma [469], and malignant tumors of the oral epithelial tissue [470,471].